← Back to search

HERON THERAPEUTICS, INC.

HRTX · NASDAQ

Pharmaceutical Preparation Manufacturing

Heron Therapeutics, Inc. is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs. Heron is developing novel, patient-focused solutions that apply its innovative science and technologies to already-approved pharmacological agents for patients suffering from pain or cancer.

ESG Scores

Overall ESG
3.2
Environmental
5.3
Social
2.7
Governance
6.5

Gender Diversity

Female Directors0.2857%
Female Executives0.27586206896551724%
CEO GenderMale

Market Data

Price$0.48+0.04 (+8.21%)
Market Cap$84M
P/E Ratio
EPS$—
52W High$2.30
52W Low$0.43
Beta1.63